Expression of RRIG1 gene mRNA in breast carcinoma and its clinicopathologic significance
XU Xiao-chun
Abstract
XU Xiao-chun
Abstract
Purpose To investigate the expression of RRIG1 mRNA and their relationships with clinicopathologic characters in breast carcinoma.Methods Real time quantitative reverse transcription polymerase chain reaction(RQ RT-PCR) technique was applied for detecting RRIG1 mRNA expression in 76 cases of breast carcinoma,5 cases of ductal carcinoma in situ and 20 cases of breast benign lesions.Results The level of mRNA expression of RRIG1 gene was significantly higher in breast benign 1esions(10.2±6.5) than in ductal carcinoma in situ(3.5±2.1) and invasive breast carcinoma(6.7±4.1)(P=0.004 and 0.036,respectively).RRIG1 mRNA expression is significantly lower in lymph node positive(5.2±3.1) than in non lymph node negative cases(7.48±4.5)(P=0.023).Conclusions RRIG1 may play a important role in disease occurrence and progression of breast carcinoma,RRIG1 may be a new biomarker for early diagnosis and prognosis in breast cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Purpose To investigate the expression of RRIG1 mRNA and their relationships with clinicopathologic characters in breast carcinoma.Methods Real time quantitative reverse transcription polymerase chain reaction(RQ RT-PCR) technique was applied for detecting RRIG1 mRNA expression in 76 cases of breast carcinoma,5 cases of ductal carcinoma in situ and 20 cases of breast benign lesions.Results The level of mRNA expression of RRIG1 gene was significantly higher in breast benign 1esions(10.2±6.5) than in ductal carcinoma in situ(3.5±2.1) and invasive breast carcinoma(6.7±4.1)(P=0.004 and 0.036,respectively).RRIG1 mRNA expression is significantly lower in lymph node positive(5.2±3.1) than in non lymph node negative cases(7.48±4.5)(P=0.023).Conclusions RRIG1 may play a important role in disease occurrence and progression of breast carcinoma,RRIG1 may be a new biomarker for early diagnosis and prognosis in breast cancer.
Key concepts: Breast cancer, Breast carcinoma, Ductal carcinoma, Messenger RNA, Pathology, Lymph node, Carcinoma, Reverse transcription polymerase chain reaction